CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 43 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $110,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JBF Capital, Inc. | 520,553 | $161,000 | 0.03% |
| Kalos Management, Inc. | 43,940 | $13,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,351,000 | $419,000 | 0.00% |
| Quilter Plc | 60,546 | $19,000 | 0.00% |
| ALBION FINANCIAL GROUP /UT | 12,000 | $4,000 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $7,000 | 0.00% |
| MORGAN STANLEY | 1,900 | $1,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $8,000 | 0.00% |
| BlackRock Inc. | 645,611 | $200,000 | 0.00% |
| Bank of New York Mellon Corp | 137,500 | $43,000 | 0.00% |